Feasibility of Outpatient Administration of Ciltacabtagene Autoleucel for the Treatment of Relapsed Refractory Multiple Myeloma: The Vanderbilt Experience
20260 citationsJournal Article
Field-Weighted Citation Impact: 0.00
Feasibility of Outpatient Administration of Ciltacabtagene Autoleucel for the Treatment of Relapsed Refractory Multiple Myeloma: The Vanderbilt Experience | Researchclopedia